Gregg C Fonarow Selected Research

Angiotensin Receptors (Angiotensin II Receptor)

6/2022	Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.
1/2022	Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry.
1/2022	Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction.
3/2021	The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction.
1/2021	Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
11/2020	Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
12/2019	Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF).
1/2019	Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.
1/2019	Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
1/2019	Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregg C Fonarow Research Topics

Disease

429	Heart Failure 07/2022 - 01/2002
110	Stroke (Strokes) 01/2022 - 05/2008
104	Atrial Fibrillation 01/2022 - 11/2007
80	Ischemic Stroke 01/2022 - 01/2009
72	Myocardial Infarction 01/2022 - 03/2002
54	Hemorrhage 06/2022 - 04/2011
37	Coronary Artery Disease (Coronary Atherosclerosis) 09/2021 - 05/2002
35	Acute Coronary Syndrome 06/2022 - 05/2002
30	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 08/2002
30	Left Ventricular Dysfunction 01/2020 - 01/2003
28	Hypertension (High Blood Pressure) 07/2022 - 06/2002
27	ST Elevation Myocardial Infarction 01/2022 - 10/2004
22	Chronic Renal Insufficiency 09/2021 - 02/2009
20	Diabetes Mellitus 01/2021 - 01/2007
18	Systolic Heart Failure 11/2014 - 12/2006
16	Renal Insufficiency (Renal Failure) 07/2022 - 01/2006
16	Atherosclerosis 08/2014 - 08/2002
13	Cardiogenic Shock 05/2022 - 09/2005
13	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 06/2012
13	Inflammation (Inflammations) 07/2020 - 01/2003
13	Transient Ischemic Attack 01/2018 - 01/2009
11	Cerebral Hemorrhage 01/2021 - 10/2010
9	Acute Kidney Injury (Acute Renal Failure) 05/2022 - 11/2013
9	Heart Arrest (Cardiac Arrest) 01/2022 - 10/2007
9	Dyspnea (Shortness of Breath) 11/2021 - 01/2007
9	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2002
9	Vascular Diseases (Vascular Disease) 01/2020 - 08/2002
9	Thrombosis (Thrombus) 11/2019 - 11/2005
8	Hypotension (Low Blood Pressure) 05/2022 - 12/2006
8	Type 2 Diabetes Mellitus (MODY) 11/2020 - 05/2009
8	Cardiomyopathies (Cardiomyopathy) 01/2020 - 08/2008
8	Obesity 05/2016 - 01/2002
8	Anemia 10/2013 - 06/2002
7	Frailty 01/2022 - 07/2013
7	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 01/2003
7	Hyperkalemia 12/2017 - 06/2012
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 05/2011
6	COVID-19 01/2022 - 07/2020
6	Overweight 01/2021 - 05/2009
6	Hyperlipidemias (Hyperlipidemia) 01/2020 - 01/2009

Drug/Important Bio-Agent (IBA)

77	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2002
50	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2002
47	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2002
47	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 02/2011
44	LipidsIBA 01/2022 - 01/2002
37	AnticoagulantsIBA 01/2022 - 04/2010
36	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2009
34	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 03/2002
33	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 01/2003
28	CreatinineIBA 09/2021 - 06/2006
25	SodiumIBA 01/2022 - 06/2002
24	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 01/2003
19	DiureticsIBA 11/2021 - 01/2002
19	CholesterolIBA 01/2018 - 08/2002
18	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021 - 01/2016
18	Pharmaceutical PreparationsIBA 09/2021 - 11/2008
17	Neprilysin (Neutral Endopeptidase)IBA 06/2022 - 01/2016
17	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2022 - 09/2012
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2005
15	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2010
15	oxidized low density lipoproteinIBA 01/2021 - 08/2002
15	Digoxin (Digitek)FDA LinkGeneric 12/2020 - 01/2012
14	Hemoglobins (Hemoglobin)IBA 01/2021 - 06/2002
13	Vitamin K FDA Link 01/2022 - 05/2012
12	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2020 - 05/2002
12	TroponinIBA 07/2020 - 01/2003
11	Natriuretic PeptidesIBA 01/2022 - 01/2002
11	Clopidogrel (Plavix)FDA Link 12/2021 - 05/2002
10	Antihypertensive Agents (Antihypertensives)IBA 07/2022 - 05/2002
10	Dabigatran FDA Link 01/2021 - 11/2013
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2005
10	LDL CholesterolIBA 01/2021 - 08/2002
10	NitrogenIBA 12/2017 - 01/2006
10	Urea (Carbamide)FDA LinkGeneric 12/2017 - 01/2006
9	N(4)-oleylcytosine arabinosideIBA 01/2018 - 07/2015
9	LDL Lipoproteins (beta Lipoproteins)IBA 11/2014 - 12/2005
9	Carvedilol (Coreg)FDA LinkGeneric 05/2009 - 01/2003
8	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 06/2006
8	CarbohydratesIBA 01/2021 - 07/2010
8	RivaroxabanIBA 01/2021 - 11/2013
7	Sodium-Glucose Transport ProteinsIBA 03/2021 - 12/2019
7	Hydralazine (Apresoline)FDA LinkGeneric 12/2019 - 02/2009
7	Vasopressins (Vasopressin)IBA 04/2016 - 02/2013
7	Tolvaptan FDA Link 04/2016 - 02/2013
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2022 - 05/2002
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 12/2019
6	Enalapril FDA LinkGeneric 11/2020 - 07/2013

Therapy/Procedure

318	Therapeutics 07/2022 - 01/2002
55	Patient Readmission 07/2022 - 01/2003
49	Length of Stay 05/2022 - 07/2004
43	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020 - 10/2007
37	Percutaneous Coronary Intervention 06/2022 - 11/2003
31	Cardiac Resynchronization Therapy 01/2020 - 01/2007
24	Secondary Prevention 01/2022 - 06/2003
20	Contraindications 06/2022 - 09/2006
18	Thrombolytic Therapy 01/2022 - 07/2010
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 05/2007
7	Drug Therapy (Chemotherapy) 09/2021 - 08/2002
6	Heart-Assist Devices 11/2021 - 05/2013
6	Cardiac Rehabilitation 01/2021 - 09/2007